My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 148

    1.

    Predictors of health care costs in adults with diabetes.

    Gilmer TP, O'Connor PJ, Rush WA, Crain AL, Whitebird RR, Hanson AM, Solberg LI.

    Diabetes Care. 2005 Jan;28(1):59-64.PMID: 15616234 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Impact of office systems and improvement strategies on costs of care for adults with diabetes.

    Gilmer TP, O'Connor PJ, Rush WA, Crain AL, Whitebird RR, Hanson AM, Solberg LI.

    Diabetes Care. 2006 Jun;29(6):1242-8.PMID: 16732003 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Relationship of glycemic control to total diabetes-related costs for managed care health plan members with type 2 diabetes.

    Shetty S, Secnik K, Oglesby AK.

    J Manag Care Pharm. 2005 Sep;11(7):559-64.PMID: 16137213 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The cost of medical care for patients with diabetes, hypertension and both conditions: does alcohol use play a role?

    French MT, Mundt MP, Fleming M, Zavala SK.

    J Intern Med. 2005 Jul;258(1):45-54.PMID: 15953132 [PubMed - indexed for MEDLINE]Related articles

    5.

    The cost to health plans of poor glycemic control.

    Gilmer TP, O'Connor PJ, Manning WG, Rush WA.

    Diabetes Care. 1997 Dec;20(12):1847-53.PMID: 9405905 [PubMed - indexed for MEDLINE]Related articles

    6.

    Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease.

    Gandra SR, Lawrence LW, Parasuraman BM, Darin RM, Sherman JJ, Wall JL.

    J Manag Care Pharm. 2006 Sep;12(7):546-54.PMID: 16981800 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data.

    Yu AP, Wu EQ, Birnbaum HG, Emani S, Fay M, Pohl G, Wintle M, Yang E, Oglesby A.

    Curr Med Res Opin. 2007 Sep;23(9):2157-69. Review.PMID: 17669232 [PubMed - indexed for MEDLINE]Related articles

    8.

    Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.

    Wu EQ, Birnbaum HG, Zhang HF, Ivanova JI, Yang E, Mallet D.

    J Manag Care Pharm. 2007 Sep;13(7):561-9.PMID: 17874862 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.

    Khandker RK, Kruzikas DT, McLaughlin TP.

    J Manag Care Pharm. 2008 Jun;14(5):426-41.PMID: 18597572 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000.

    O'Brien JA, Patrick AR, Caro J.

    Clin Ther. 2003 Mar;25(3):1017-38.PMID: 12852716 [PubMed - indexed for MEDLINE]Related articles

    11.

    Impact of a managed-Medicare physical activity benefit on health care utilization and costs in older adults with diabetes.

    Nguyen HQ, Ackermann RT, Berke EM, Cheadle A, Williams B, Lin E, Maciejewski ML, LoGerfo JP.

    Diabetes Care. 2007 Jan;30(1):43-8.PMID: 17192331 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Understanding the gap between good processes of diabetes care and poor intermediate outcomes: Translating Research into Action for Diabetes (TRIAD).

    Selby JV, Swain BE, Gerzoff RB, Karter AJ, Waitzfelder BE, Brown AF, Ackermann RT, Duru OK, Ferrara A, Herman W, Marrero DG, Caputo D, Narayan KM; TRIAD Study Group.

    Med Care. 2007 Dec;45(12):1144-53.PMID: 18007164 [PubMed - indexed for MEDLINE]Related articles

    13.

    Modelling cost effectiveness of insulin glargine for the treatment of type 1 and 2 diabetes in Canada.

    Grima DT, Thompson MF, Sauriol L.

    Pharmacoeconomics. 2007;25(3):253-66.PMID: 17335310 [PubMed - indexed for MEDLINE]Related articles

    14.

    Costs of lower-extremity ulcers among patients with diabetes.

    Stockl K, Vanderplas A, Tafesse E, Chang E.

    Diabetes Care. 2004 Sep;27(9):2129-34.PMID: 15333473 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis.

    Brown JB, Nichols GA, Glauber HS, Bakst AW.

    Diabetes Care. 1999 Jul;22(7):1116-24.PMID: 10388977 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Characteristics and baseline clinical predictors of future fatal versus nonfatal coronary heart disease events in older adults: the Cardiovascular Health Study.

    Pearte CA, Furberg CD, O'Meara ES, Psaty BM, Kuller L, Powe NR, Manolio T.

    Circulation. 2006 May 9;113(18):2177-85. Epub 2006 May 1.PMID: 16651468 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4).

    Martin S, Schramm W, Schneider B, Neeser K, Weber C, Lodwig V, Heinemann L, Scherbaum WA, Kolb H.

    Exp Clin Endocrinol Diabetes. 2007 Sep;115(8):495-501.PMID: 17853332 [PubMed - indexed for MEDLINE]Related articles

    18.

    Patterns and costs of hospital care for coronary heart disease related and not related to diabetes.

    Currie CJ, Morgan CL, Peters JR.

    Heart. 1997 Dec;78(6):544-9.PMID: 9470868 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events.

    Albert MA, Glynn RJ, Buring J, Ridker PM.

    Circulation. 2006 Dec 12;114(24):2619-26. Epub 2006 Nov 20.PMID: 17116764 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Lifetime costs of complications resulting from type 2 diabetes in the U.S.

    Caro JJ, Ward AJ, O'Brien JA.

    Diabetes Care. 2002 Mar;25(3):476-81.PMID: 11874933 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity